HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea (Q85289449)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 September 2014

Language	Label	Description	Also known as
English	HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea	scientific article published on 11 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Peter N Weissman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Molly C Carr

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

June Ye

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Deborah T Cirkel

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Murray Stewart

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Caroline Perry

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Richard Pratley

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

11 September 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

57

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2475-2484

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25208756%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

https://scigraph.springernature.com/pub.10.1007/s00125-014-3360-3

0 references

A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initiating basal insulin therapy in type 2 diabetes: practical steps to optimize glycemic control

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards of medical care in diabetes--2013

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uncovering undetected hypoglycemic events

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AACE comprehensive diabetes management algorithm 2013.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-associated weight gain in diabetes--causes, effects and coping strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoglycemia rates with basal insulin analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir

1 reference

https://pubmed.ncbi.nlm.nih.gov/25208756

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85289449&oldid=1563408972"